A case series from Colorado raises concern over significant radiation necrosis with SRS. However, there doesn't seem to be much additional negative li...
New answer by Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center (October 22, 2018)
This is an increasingly common clinical scenario, because systemic control with antibodies is quite good, but HER2+ disease still has a strong predilection for the brain. The...